Fluticasone + Umeclidinium + Vilanterol

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandDoseManufacturer
Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhalerGB—GlaxoSmithKline UK Ltd
Generic Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhalerGB—GlaxoSmithKline UK Ltd
fluticasona + umeclidinio + vilanterolES0.092 mg / 0.055 mg / 0.022 mgGlaxosmithkline Trading Services Limited
ELEBRATO ELLIPTAESEU0.092 mg / 0.055 mg / 0.022 mgGlaxoSmithKline Trading Services Limited
TEMYBRIC ELLIPTAESEU0.092 mg / 0.055 mg / 0.022 mgGlaxoSmithKline Trading Services Limited
Trelegy Ellipta 100/62.5/25AU0.1 mg / 0.0625 mg / 0.025 mg / 0.2 mgGlaxoSmithKline Australia Pty Ltd
fluticasone furoate + umeclidinium + vilanterolAU0.1 mg / 0.0625 mg / 0.025 mg / 0.2 mgGlaxoSmithKline Australia Pty Ltd
TRELEGY ELLIPTA INHALATION POWDER, PRE-DISPENSED 100MCG/62.5MCG/25MCGHK—GLAXOSMITHKLINE LIMITED
TRELEGYMX—GlaxoSmithKline México, S.A. de C.V.

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.